FOXP3 and breast carcinoma: The latter is in agreement with Gregg et al56 showing that circulating Tregs are increasing with age in healthy subjects, while it appears that the observed higher mRNA expression of FOXP3 in postmenopausal women with breast cancer is reflecting the general increase in Tregs with age.